High-Efficiency FLP and ΦC31 Site-Specific Recombination in Mammalian Cells by Raymond, Christopher S. & Soriano, Philippe
High-Efficiency FLP and WC31 Site-Specific
Recombination in Mammalian Cells
Christopher S. Raymond, Philippe Soriano*
Program in Developmental Biology, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of
America
DNA site-specific recombinases (SSRs) such as Cre, FLPe, and wC31, are powerful tools for analyzing gene function in
vertebrates. While the availability of multiple high-efficiency SSRs would facilitate a wide array of genomic engineering
possibilities, efficient recombination in mammalian cells has only been observed with Cre recombinase. Here we report the de
novo synthesis of mouse codon-optimized FLP (FLPo) and WC31 (WC31o) SSRs, which result in recombination efficiencies
similar to Cre.
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INTRODUCTION
The use of site-specific recombinases (SSRs) both in vitro and in vivo,
have proven to be useful tools in the analysis of gene function.
Upon binding to their target recognition sequences, SSRs can
induce the deletion, insertion, or inversion of DNA sequences
leading to conditional gene inactivation or expression [1]. The first
widely used SSR in mammalian cultured cells and animals was the
P1 bacteriophage-derived Cre, a member of the l integrase family
that recognizes homotypic 34 bp loxP recognition sites [2,3]. To
date, Cre recombinase remains the most efficient only SSR to
efficiently mediate DNA recombination both in vitro and in vivo.A
second SSR from the l integrase family, FLP from Saccharomyces
cerevisiae, has also been used in mammals [4] and recognizes
distinct 34 bp FRT sites [5]. Initial use of FLP in mammalian cells
revealed inefficient recombinase activity due to thermo-instability
of the protein [6]. Subsequent screening for thermo-stable mutants
resulted in the identification of FLPe, with a 4-fold increase in
recombination efficiency [7]. Despite this improvement, the
recombination efficiency of FLPe in cells remains quite low, at
most a 6%, with mosaic recombination found in almost all ES
clones [8]. A third SSR, WC31 from Streptomyces lividans, also displays
activity in mammalian cells [9,10]. Unlike Cre and FLP, WC31
mediates DNA recombination at heterotypic binding sequences
known as attB and attP sites [10]. Upon recombination of these
target sites, hybrid attL or attR sites are created which are refractive
to further recombination, locking the newly formed sequences into
place [10], a distinct feature desirable in many molecular
applications. Although one report suggests that WC31 may be
nearlyasefficientasCreinmediatingrecombinationinculturedcells
[11], others have indicated more limited success [9] and thus the
broad utility of this recombinase as a tool remains to be established.
In this manuscript we now report that the de novo synthesis of mouse
codon-optimized FLP (FLPo) and WC31 (WC31o) SSRs result in
DNA recombination efficiencies similar to that of Cre.
RESULTS AND DISCUSSION
One reason for the observed varying degrees of efficiency of SSRs
in mammalian cells may be their non-mammalian origin.
Achieving high steady-state expression levels of non-endogenous
genes in mammalian systems can be difficult, due to differences in
amino acid codon usage, or the presence of cryptic splice
acceptor/donor sites since these genes do not normally undergo
splicing in the native host. To improve their translational efficiency
in mammalian cells, FLPe and WC31 recombinases were re-
engineered de novo according to the native amino acid sequence but
with mouse codon usage (Figures S1 & S2). The final WC31 and
FLP DNA coding sequence optimization was designed using the
GeneOptimizer software algorithm (Geneart GmbH, Regensburg,
Germany; http://www.geneart.com/). During the optimization
process a number of sequence motifs were avoided, including
internal TATA-boxes, ribosomal entry sites, stretches of AT- and
GC-rich sequence, repeat sequences, RNA secondary structure,
and cryptic splice and polyadenylation sites (for review on
synthetic gene design see [12]). Additionally, the codon-optimized
WC31 gene (WC31optimized or WC31o) was synthesized with
a reduced number of CpG dinucleotides, to avoid gene silencing
associated with DNA methylation at such sites [13]. Last, the
overall base composition of the codon-optimized FLPe gene (FLP
optimized or FLPo) was modified to prolong mRNA half-life, since
genes with low G/C content often result in less stable mRNAs and
low levels of expression. Two stop codons were included in the
optimized SSRs to ensure efficient translational termination.
Recombination activity of the re-engineered FLPo and WC31o
were directly compared in appropriate ROSA26 based ES reporter
lines to the native FLPe and WC31 sequences, as well as to Cre
(Figure 1A). To allow a direct comparison between SSRs, all expres-
sion constructs were driven by the phosphoglycerate kinase 1 (PGK)
promoter, included a Kozak consensus translational start sequence,
an SV40 nuclear localization signal, and were terminated by a bovine
growth hormone polyadenylation sequence. Since a multitude of
changes were made across the entire coding sequences of the codon-
optimized recombinases, any potential observed differences in DNA
recombination activity would be due to the combined effects of
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process. Recombination activity for WC31 and WC31o was assessed
in R26attR reporter ES cells that contain a b-galactosidase gene
disrupted by an attB and attP-flanked stop cassette (Figure S3).
The results of these stable transfection assays (Figure 1B)
indicate that codon-optimization of the FLPe and WC31 genes
significantly improves recombination activity in ES cells, to a level
similar to that observed with Cre recombinase. Analysis of X-gal
Figure 1. Recombination analysis of SSR activity on stably transfected ES cells. (A) Schematic diagram of SSR reporter assay system. A WC31 b-
galactosidase reporter ES cell line was constructed at the ROSA26 locus [14], except that the stop cassette was flanked by minimal 35 bp attB and
39 bp attP target DNA recognition sites[10]. These ES cells were used to generate a WC31 reporter mouse strain. (B) ES reporter cell lines for Cre [14],
FLP [16], and WC31 (described within) were stably co-transfected with linearized SSR and PGKHygromycin. SSR-mediated recombination activity was
assessed on hygromycin-resistant ES cell colonies by X-gal (Cre and WC31) and AP staining (FLP). Variable degrees of recombination were observed in
colonies, as judged by the percentage of cells reacting with X-Gal; representative ES cell colonies are shown. N.D.- not detected.
doi:10.1371/journal.pone.0000162.g001
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complete Cre-mediated recombination activity when harboring an
integrated PGKCre expression vector compared to reporter cell
line alone. However, ES cell colonies containing an integrated
WC31 expression construct showed either no or very mosaic X-
Gal staining. In marked contrast, most ES cell clones containing
an integrated codon-optimized WC31o construct displayed robust
X-gal staining. We next performed alkaline phosphatase staining
on FLP reporter ES cells and observed no recombination
mediated by the native FLPe gene (although using pCAGGS-
FLPe we observed ,5% of clones with mosaic recombination, as
previously described [8]). In contrast, the majority of the ES
colonies displayed efficient FLP-mediated recombination activity
when containing an integrated codon-optimized FLPo expression
vector. These results indicate that Cre, FLPo and WC31o, all
achieve similar recombination efficiency in ES cells.
Based on the promising activity of WC31o in mediating recom-
bination events in ES cells, we tested recombination efficiency in
vivo by targeting the coding sequences of WC31 and the codon-
optimized WC31o to the broadly expressed ROSA26 locus [14]
(Figure 2A). Such strains would potentially allow for more complex
genetic analysis when used in combination with Cre and FLP
expressing mouse strains. Although continued expression of WC31
has been shown to lead to chromosomal aberrations in primary
human fibroblasts [15], R26WC31 and R26WC31o heterozygous
or homozygous mice were viable and neither showed any obvious
deleterious effects from the widespread expression of the SSR.
Recombination activity was assessed by crossing R26WC31 and
R26WC31o mice to the R26attR reporter mouse strain. E10.5
embryos carrying the R26attR reporter allele alone exhibited no
background X-gal staining (data not shown). R26WC31; R26attR
compound heterozygotes exhibited a variable low-level mosaic
pattern of X-Gal staining (Figure 2B). In contrast, R26WC31o;
R26attR embryos exhibited broad X-gal staining (Figure 2C),
although sectioning (Figure 2D) revealed that recombination was
not as efficient as was observed in R26Cre; R26R embryos [14].
The use of multiple, highly efficient SSRs in ES cells and mice
now opens possibilities for a broader range of molecular mani-
pulations. These not only include the potential for additional
genetic alterations during ES cell expansion (such as removal of
selectable markers) and performing multiple general or tissue-
specific gene knockouts, but also for studying gene function in
over-lapping domains of expression. Additionally, the use of
multiple SSRs could potentially be used for controlling gene
Figure 2. Analysis of R26WC31 and R26WC31o activity in vivo. (A) Diagram of WC31 and WC31o knock-in vectors targeted to the ROSA26 locus.
Whole mount X-Gal staining of E10.5 (B) R26WC31; R26attR and (C) R26WC31o; R26attR compound heterozygous embryos. (D) Sagittal section of X-
Gal stained E10.5 R26WC31o; R26attR compound heterozygote.
doi:10.1371/journal.pone.0000162.g002
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cell types or tissues. The optimized WC31o and FLPo expression
constructs will be made available to academic researchers through
the Addgene plasmid repository (http://www.addgene.org/).
MATERIALS AND METHODS
Construction of site-specific recombinase expression
vectors
The coding sequence of FLPo and WC31o was commercially
synthesized de novo (Geneart GmbH, Regensburg, Germany) based
on the published FLPe and WC31 coding sequence [8,11]. The
coding sequence of endogenous WC31 was PCR-amplified from
phage lysate (Deutsche Sammlung von Mikroorganismen und
Zellkulturen (DSMZ) GmbH, Braunschweig, Germany). A C-
terminal SV40 nuclear localization signal was also added to the
endogenous WC31 coding sequence as previously described [11].
The FLPo, WC31o, and WC31 coding sequences were blunt cloned
into mammalian expression vectors driven by the high expressing
phosphoglycerate kinase 1 (PGK) promoter and containing the
bovine growth hormone polyadenylation (bpA) sequence.
Reporter constructs and mice
ES cells harboring a Cre-inducible b-galactosidase or FLP-
inducible PLAP reporter gene integrated at the broadly-expressed
ROSA26 locus were used as previously described to monitor Cre
or FLP activity [14,16]. A WC31/att b-galactosidase reporter ES
cell line was constructed similarly to the above, except that the stop
cassette was flanked by the minimal target DNA recognition sites,
the 35 bp attB (GGTGCCAGGGCGTGCCCTTGGGCTCC-
CCGGGCGCG) and the 39 bp attP (CCCCAACTGGGG-
TAACCTTTGAGTTCTCTCAGTTGGGGG) [10]. These ES
cells were used to generate a WC31 reporter mouse strain gene to
monitor WC31 and WC31o DNA recombinase activity in vivo.
Similarly, the WC31o and WC31 coding sequences were blunt
cloned into the pROSA26-1 vector to generate mouse strains that
broadly express this SSR.
ES cell transfection assay
20 mg of each linearized SSR expression construct was co-
electroporated in a 10:1 molar ratio with PGKHygromycin into
corresponding ES reporter cell lines for Cre [14], FLP [16], and
WC31 (described within). After 10 days of antibiotic selection,
Hygromycin-resistant ES clones were PCR genotyped for the
presence of the SSR expression constructs and SSR-mediated
DNA recombination was assessed by AP and X-gal staining.
X-gal and AP staining
Alkaline phosphatase (FLP) and b-galactosidase (Cre and wC31)
activity in ES cells and embryos was visualized as previously
described [14,16].
SUPPORTING INFORMATION
Figure S1 Nucleotide sequence of FLPo. A mouse codon-
optimized FLP gene containing an N-terminal SV40 nuclear
localization signal was generated de novo (GENEART AG,
Regensburg, Germany) according to previously described FLPe
amino acid sequence [8].
Found at: doi:10.1371/journal.pone.0000162.s001 (0.03 MB
DOC)
Figure S2 Nucleotide sequence of WC31o. A mouse codon-
optimized WC31 gene with C-terminal SV40 nuclear localization
signal was synthesized de novo according to the native WC31
amino acid sequence (GENEART AG, Regensburg, Germany).
Found at: doi:10.1371/journal.pone.0000162.s002 (0.04 MB
DOC)
Figure S3 Establishment of ROSAattR reporter line. Diagram
of QC31 reporter knock-in vector targeted to the ROSA26 locus.
The stop cassette is flanked by 35 bp attB and 39 bp attP sites, as
previously described [10].
Found at: doi:10.1371/journal.pone.0000162.s003 (0.06 MB TIF)
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